Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.
This report contains market size and forecasts of Placental Stem Cell Therapy in Global, including the following market information:
Global Placental Stem Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Placental Stem Cell Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hematologic Malignancies and Disorders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Placental Stem Cell Therapy include Lifebank Stem Cell Banking, Cynata, Celularity, Athersys, Americord Registry, ReNeuron Group, ReeLabs, Mesoblast and Pluristem Therapeutics. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Placental Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Placental Stem Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Placental Stem Cell Therapy Market Segment Percentages, by Type, 2021 (%)
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Global Placental Stem Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Placental Stem Cell Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
Global Placental Stem Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Placental Stem Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Placental Stem Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Placental Stem Cell Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics